Combining with other weight loss agents Tesofensine + GLP-1 agonists (theoretical): Different mechanisms = potential synergy Tesofensine: Metabolic + CNS appetite GLP-1s : Strong appetite + gastric slowing Could enhance weight loss to 20-25%+ BUT: No clinical data, significant risks Not recommended without supervision Potential combination benefits: Address multiple pathways Overcome plateaus Better than either alone (theoretically) Metabolic boost + strong appetite suppression Maximum fat loss Combination risks: Compounded cardiovascular strain Unknown drug interactions Excessive weight loss risks Cost ($1,500-2,000/month) Safer alternatives to tesofensine combinations: Tirzepatide alone (15-22% loss, FDA approved) CagriSema (sema + cagrilintide, 15-25%) GLP-1 + lifestyle (safer, proven) Learn about peptide stacking strategies at SeekPeptides
10.1016/s0958-1669(00)00199-3 55 UribeP
In contrast, metabolites including betaine and 5-aminopentanoic acid , which were relatively lower at baseline, exhibited increased levels post-intervention
At your desk, ensure your screen is at eye level and your keyboard and mouse are within easy reach to reduce strain
Prospective patients should understand that enrolling with MadeMed does not guarantee a prescription - only a clinical evaluation by an independent provider
This warning extends to all medicines in these classes approved for diabetes and/or chronic weight management, including: semaglutide ( Ozempic , Wegovy ) dulaglutide ( Trulicity ) liraglutide ( Victoza, Saxenda ) tirzepatide ( Mounjaro )
